Pharmacogenetic testing by polymorphic markers 681G>A and 636G>A CYP2C19 gene in patients with acute coronary syndrome and gastric ulcer in the Republic of Sakha (Yakutia).
Denis S FedorinovKarin B MirzaevDmitriy V IvashchenkoIlyas I TemirbulatovDmitriy A SychevNadezda R MaksimovaJana V ChertovskihNyurguiana V PopovaKsenia S TayurskayaZoya A RudykhPublished in: Drug metabolism and personalized therapy (2018)
The results of the present study may be helpful for developing guidelines for CYPC19 genotype-directed antiplatelet therapy for Yakut and Russian patients.